Page last updated: 2024-09-03

27-hydroxycholesterol and Angiogenesis, Pathologic

27-hydroxycholesterol has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Hu, C; Li, Y; Li, Z; Liu, J; Liu, Y; Shen, Z; Zhu, D	1

Other Studies

1 other study(ies) available for 27-hydroxycholesterol and Angiogenesis, Pathologic

Article	Year
The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells. Toxicology letters, 2016, Dec-15, Volume: 264 Topics: Angiogenesis Inducing Agents; Autocrine Communication; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Female; Gene Knockdown Techniques; Humans; Hydroxycholesterols; Neovascularization, Pathologic; Reactive Oxygen Species; Selective Estrogen Receptor Modulators; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A	2016

Article

Year

The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells.

Toxicology letters, 2016, Dec-15, Volume: 264

Topics: Angiogenesis Inducing Agents; Autocrine Communication; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Female; Gene Knockdown Techniques; Humans; Hydroxycholesterols; Neovascularization, Pathologic; Reactive Oxygen Species; Selective Estrogen Receptor Modulators; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A

2016